Cenicriviroc: Phase IIb started

Tobira began the double-blind, placebo-controlled, international Phase IIb CENTAUR trial to evaluate 150 mg oral cenicriviroc once daily for 2 years in about 250 adults with NASH and liver fibrosis. T...